APA (7th ed.) Citation

Tang, M., Song, C., Zhang, Y., Xu, X., Wang, C., Zhang, Z., & Chen, T. (2021). Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib. BMC.

Chicago Style (17th ed.) Citation

Tang, Mengqiu, Chao Song, Yaowen Zhang, Xiaoyu Xu, Chen Wang, Zhanchun Zhang, and Tian Chen. Levels of Pretreatment Blood Lipids Are Prognostic Factors in Advanced NSCLC Patients Treated with Anlotinib. BMC, 2021.

MLA (8th ed.) Citation

Tang, Mengqiu, et al. Levels of Pretreatment Blood Lipids Are Prognostic Factors in Advanced NSCLC Patients Treated with Anlotinib. BMC, 2021.